How to Buy Cigna Group Stock
Cigna Group
Cigna Group is a healthcare plan company located in Connecticut, United States, which is part of the Healthcare sector, and is traded under the ticker CI on the NYSE exchange.
Cigna Group stock last closed at $300.48, down 0.08% from the previous day, and has decreased 17.78% in one year. It has overperformed other stocks in the Healthcare Plans industry by 0.17 percentage points. Cigna Group stock is currently +16.97% from its 52-week low of $256.89, and -18.97% from its 52-week high of $370.83.
There are currently 266.93M CI shares outstanding. The market cap of CI is $80.21B. In the last 24 hours, 1.51M CI shares were traded.
How to Buy Cigna Group Stock
Wondering how to invest in Cigna Group stock? Here's how.
- Decide where to buy Cigna Group stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Cigna Group stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Pick your payment method and add your information.
- Evaluate Cigna Group stock: The Cigna Group ticker symbol is CI. Is Cigna Group stock a good investment? Should you buy shares of CI? How do CI's underlying business fundamentals look? Do top analysts think Cigna Group is a good buy? Why has CI's stock price moved recently? (Hint: Our stock analysis website can help you figure out if CI is a good stock to buy).
- Make your CI buy order: Decide if you will purchase CI shares at the current market price or use a limit order to purchase CI stock at a particular price.
- Get notifications regarding your investment in CI: Create a watchlist to important notifications about your new investment in Cigna Group shares.
Step 1: Decide where to buy Cigna Group stock
You will need a brokerage account to access the NYSE market and buy CI stock.
Our favorite brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Tech to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected your brokerage, it's time to fill out some personal information so you can invest in CI today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create a new brokerage account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have finished signing up on stock apps to use, your next step is to transfer the money for your investment:
Check out this video walkthrough for more details transferring money into your new investment account.
Step 4: Evaluate Cigna Group stock
After you have decided on the best place to buy Cigna Group stock, it's crucial to evaluate their stock prior to investing, so you actually wrap your head around the risk and opportunity.
Overview of key CI info
Fundamentals of CI
WallStreetZen was designed to help part-time investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on CI's stock page.
Is CI stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge CI's intrinsic value.
Using relative valuations methods:
- CI may be overvalued based on its P/E ratio of 16.32x, relative to Healthcare Plans industry P/E ratio of 14.4x
- CI may be overvalued based on its P/B ratio of 1.99x, relative to Healthcare Plans industry P/B ratio of 1.94x
- CI could be undervalued based on its PEG ratio of 0.62x
You can do additional valuation research on CI's stock here.
A look at CI Cashflows and Balance Sheet
Pros:
- CI profit margin has gone up from 1.7% to 1.9% in the past year.
- CI earnings of $7.92B is not enough to cover its interest payments.
Cons:
- There are more long-term liabilities than short-term assets on the CI balance sheet.
- CI has a relatively high debt to equity ratio of 2.77.
- Total CI debt is higher than 5 years ago, relative to shareholder equity.
- CI's operating cash flow of $5.29B allows it to safely service it's debt of $30.77B.
- There are more short-term liabilities than short-term assets on the CI balance sheet.
Is CI stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 10 sell side analysts who give ratings on CI, the consensus analyst rating on Cigna Group is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
Latest CI Analyst Recommendations
Ben Hendrix, a top 20% analyst from RBC Capital reiterates CI with a buy rating and maintains their CI price target from $371.00 to $371.00, on Jun 26, 2025.
David S Macdonald, a top 12% analyst from Truist Securities maintains CI with a strong buy rating and raises their CI price target from $385.00 to $405.00, on May 12, 2025.
Truist Securities's David S Macdonald raised their price target on Cigna Group (NYSE: CI) by 5.2% from $385 to $405 on 2025/05/12. The analyst maintained their Strong Buy rating on the stock.
Cigna Group reported its Q1 2025 earnings on 2025/05/02.
In a post-print Health Service sector review, Macdonald told readers they updated their price targets after adjusting their models to account for each name's results and guidance.
Earnings Report
For Q1 2025, Cigna Group reported:
- EPS of $6.74, which beat the Zacks Consensus Estimate of $6.39 and, by 4.2%, Q1 2024’s $6.47.
- Revenue of $65.45B, which beat the Zacks Consensus Estimate by 7.66% and, by 14%, Q1 2024’s $57.25B.
For FY 2025, management guided:
- EPS of $29.60
Chairman & CEO David M. Cordani commented: "We are building a more sustainable health care model by successfully delivering on our series of commitments and actions to improve transparency and support for our customers and patients.
"Our strong Q1 results and increase in outlook for FY earnings reflect the strength of our Evernorth Health Services and Cigna Healthcare growth platforms in a dynamic environment."
Jessica Tassan, a top 37% analyst from Piper Sandler maintains CI with a strong buy rating and raises their CI price target from $348.00 to $374.00, on May 5, 2025.
John Ransom, a top 11% analyst from Raymond James maintains CI with a strong buy rating and raises their CI price target from $360.00 to $385.00, on May 5, 2025.
Erin Wright, a top 6% analyst from Morgan Stanley maintains CI with a strong buy rating and raises their CI price target from $379.00 to $390.00, on May 5, 2025.
You can dig deeper into what analysts are saying on the Cigna Group stock forecast page.
CI Momentum
CI Performance Numbers
Last year, CI earnings were $5.02B. Over the last five year, CI's earnings have gone up by 5.33% per year. This was faster than the Healthcare Plans industry average of 1.03%.
Last year, CI revenue was $262.02B. In the last five year, CI's revenue has gone up by 11.14% per year. This was slower than the Healthcare Plans industry average of 11.55%.
You can analyze CI's earnings and revenue performance here.
Are CI insiders buying or selling the stock?
In the past 12 months, executives and large shareholders at CI have sold more shares than they have bought.
David J. Brailer, EVP Chief Health Officer of CI, was the latest CI insider to sell. They sold $87,191.40 worth of CI stock on Aug 29, 2025.
Dig into more about who owns CI stock here.
Does CI stock generate passive income?
No, Cigna Group doesn't provide an income stream by paying out dividends.
What do other traders have to say about CI?
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your CI buy order
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually fine. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount limit, place a limit order.
Press the Open Trade button and eToro will execute your order.
If you want additional assistance buying stocks on eToro, click the helpful video below:
Step 6: Get notifications regarding your investment in CI
Now that you own some CI stock, you'll want to keep up with your investment.
Add CI to a watchlist to get the latest updates about your CI stock.
CI Feed
How to Buy Stock in Cigna Group
To reiterate, here are the 6 steps you need to take to buy Cigna Group stock right now:
- Decide where to buy Cigna Group stock
- Create a brokerage account
- Put funds into your brokerage account
- Evaluate Cigna Group stock
- Make your CI buy order
- Get notifications regarding your investment in CI
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get updates on your investment in Cigna Group, create a watchlist today.
Other "How To" Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.